In This Section
Selwyn M. Vickers, MD

Selwyn M. Vickers, MD

Memorial Sloan Kettering Cancer Center|
New York, New York

Class of 2024

For seminal contributions to characterizing and targeting pancreas cancer metastasis, development of oncolytic adenoviruses capable of inhibiting pancreas tumor stem cells, and instrumental efforts to develop and evaluate the efficacy of minnelide, a synthetic prodrug of the diterpene triepoxide triptolide, as a pro-apoptotic chemotherapeutic for the treatment of pancreas and hepatocellular carcinoma.

*Full-length biography pending